Edwards Lifesciences Corporation · EW · Next earnings

Edwards Lifesciences Corporation reports Thursday, Oct 29, 2026

EW reports after market close with consensus EPS at $0.73 and revenue at $1.68B. Last quarter: Edwards Lifesciences Beats on Q2, Raises Full-Year Sales Guidance

Reports After market close39 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.73 Calendar consensus
Consensus revenue $1.68B Calendar consensus
Report date Oct 29, 2026 Thursday, date estimated
Session After market close 39 days away

Where EW left off: FY2026 Q2

Full report

Edwards Lifesciences Beats on Q2, Raises Full-Year Sales Guidance

EPS surprise +5.0% Reported $0.78 vs $0.74
Revenue surprise +2.4% Reported $1.74B vs $1.70B
Stock move -1.4% Event window
Subsequent drift +3.8% Up to 20 sessions

Management raised full-year 2026 sales growth guidance from 8-10% to 10-11%. TAVR growth guidance was increased to 8-9%, and TMTT revenue guidance was introduced at $760-780 million. The earnings outlook was reaffirmed despite tax and FX headwinds.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Effective tax rate pressure from Pillar Two and California R&D credit limitations
  • Foreign-exchange headwinds reducing gross margin and potentially impacting Q3 performance
  • Regulatory uncertainty around CMS NCD finalization (expected September 2026) and pending FDA approvals for next-gen products

Questions analysts left open

  • Competitive share shift and impact of recent competitor exit on TAVR market
  • Potential revenue impact of the PROGRESS trial results and timeline for FDA approval
  • Seasonality effects and Q3 growth assumptions
  • Scope and timing of the CMS NCD final policy and its effect on center eligibility
  • Inflection point for EVOQUE adoption versus broader TMTT performance

Ask FN2 about EW next report

Transcript, numbers and history already loaded
What should I watch for in EW's next earnings report?How did EW guide last quarter, and is consensus above or below that?Give me the bull and bear case going into EW earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the EW recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent EW quarters

All EW earnings
-1.4%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q2

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.